WO2017134146A9 - Gpbp inhibitors and uses and scaleable synthesis thereof - Google Patents

Gpbp inhibitors and uses and scaleable synthesis thereof Download PDF

Info

Publication number
WO2017134146A9
WO2017134146A9 PCT/EP2017/052220 EP2017052220W WO2017134146A9 WO 2017134146 A9 WO2017134146 A9 WO 2017134146A9 EP 2017052220 W EP2017052220 W EP 2017052220W WO 2017134146 A9 WO2017134146 A9 WO 2017134146A9
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
emt
gpbp inhibitors
scaleable synthesis
scaleable
Prior art date
Application number
PCT/EP2017/052220
Other languages
French (fr)
Other versions
WO2017134146A1 (en
Inventor
Juan Saus
Raul Blasco
Francisco Revert-Ros
Fernando Revert
Nuria Roda
Original Assignee
Fibrostatin, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrostatin, S.L. filed Critical Fibrostatin, S.L.
Publication of WO2017134146A1 publication Critical patent/WO2017134146A1/en
Publication of WO2017134146A9 publication Critical patent/WO2017134146A9/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/74—Unsaturated compounds containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Abstract

The present invention provides compounds and compositions thereof that inhibit Goodpasture antigen binding protein. Also disclosed is use of the compounds for the treatment various diseases and disorders, including invasive tumors, for the inhibition of mesenchymal phenotype after epithelial-to- mesenchymal transition (EMT), and for detecting EMT in a tissue. A method of preparing the compounds of the invention and related compounds is also provided.
PCT/EP2017/052220 2016-02-02 2017-02-02 Gpbp inhibitors and uses and scaleable synthesis thereof WO2017134146A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662290238P 2016-02-02 2016-02-02
US62/290,238 2016-02-02
US201662310395P 2016-03-18 2016-03-18
US62/310,395 2016-03-18

Publications (2)

Publication Number Publication Date
WO2017134146A1 WO2017134146A1 (en) 2017-08-10
WO2017134146A9 true WO2017134146A9 (en) 2019-06-20

Family

ID=57984925

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2017/052220 WO2017134146A1 (en) 2016-02-02 2017-02-02 Gpbp inhibitors and uses and scaleable synthesis thereof

Country Status (1)

Country Link
WO (1) WO2017134146A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586776B2 (en) * 2009-11-05 2013-11-19 Fibrostatin, S.L. GPBP inhibition using Q2 peptidomimetics
JP2015524385A (en) * 2012-07-02 2015-08-24 フィブロスタティン，エス．エル． GPBP-1 inhibition and therapeutic use thereof

Also Published As

Publication number Publication date
WO2017134146A1 (en) 2017-08-10

Similar Documents

Publication Publication Date Title
SA519401020B1 (en) N-(phenylsulfonyl)benzamides and related compounds as b-cell lymphoma-2 protein inhibitors
MX2018015853A (en) Multispecific antibodies against cd40 and cd137.
MX2014000518A (en) Inhibitors of bruton's tyrosine kinase.
MX2017016655A (en) Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation methods thereof.
WO2010009342A3 (en) Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
EA033689B9 (en) Inhibitors of kras g12c
TW201613644A (en) Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, and/or a JAK-2 inhibitor
PH12015501868A1 (en) Inhibitors of histone demethylases
PH12015502792A1 (en) Crystalline bromodomain inhibitors
MX2017001656A (en) Bruton's tyrosine kinase inhibitor combinations and uses thereof.
NZ764151A (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof
MX2019009501A (en) Amino pyrimidine compounds useful as ssao inhibitors.
EP2576549A4 (en) Bicyclic heteroaryl kinase inhibitors and methods of use
MX2012004258A (en) Inhibitors of bruton's tyrosine kinase.
MX2018011102A (en) Combinations of lsd1 inhibitors for use in the treatment of solid tumors.
WO2010068483A3 (en) Mlk inhibitors and methods of use
EP3873905A4 (en) Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors
EA201790085A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
MX336051B (en) Diarylacetylene hydrazide containing tyrosine kinase inhibitors.
WO2016109217A3 (en) Btk inhibitors
TW201625535A (en) Inhibitors of histone demethylases
PH12016502353A1 (en) Pharmaceutical composition
TW201613577A (en) Pharmaceutical combinations
EP2563794A4 (en) Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders
MX2017003466A (en) Histone demethylase inhibitors.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17703712

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17703712

Country of ref document: EP

Kind code of ref document: A1